Sujoy Dasgupta: Fertility Preservation in Children Receiving Gonadotoxic Therapies
Sujoy Dasgupta, Director of Clinical Services at Genome The Fertility Centre, shared a post on LinkedIn:
“Cancer treatment in men especially chemotherapy, radiation to genitals, groin, lower abdomen and rectum and some surgery for testicular tumour often affects the capacity to reproduce. Fertility preservation is possible before cancer treatment by collecting sperms and freezing them so that the affected man can become biological father even after completing cancer treatment. However, sperm freezing poses a challenge in young boys who cannot produce semen or cannot masturbate.
Here is the European Society of Human Reproduction and Embryology (ESHRE) ‘Good practice recommendations on fertility preservation involving testicular tissue cryopreservation in children receiving gonadotoxic therapies’.
Yours truly was one of the ‘experts participating in the stakeholder review’.”
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Dec 14, 2025, 06:53New Data on Assisted Hatching in Assisted Reproduction – C.L.A.R. Consulting
-
Dec 14, 2025, 04:40Murat Levent Dereli: Monochorionic-Monoamniotic Twin with Aberrant Vascular Anastomosis
-
Dec 14, 2025, 04:18Impact of Basic Income on Health – The Center for Social Development at Washington University in St. Louis
-
Dec 14, 2025, 04:14Immune Regulation Insights from RaFJC Conference – Reproduction and Fertility
-
Dec 14, 2025, 04:07Jacques Maas: Transformative Strategies for Endometriosis and Adenomyosis
-
Dec 14, 2025, 04:04Caroline Ford: Reflects on a Journey in Gynaecological Cancer
-
Dec 14, 2025, 04:00Economic Impact of Endometriosis in New Zealand Revealed – Endometriosis New Zealand
-
Dec 14, 2025, 03:57Lone Hummelshoj: Exploring Experimental Models in Endometriosis and Adenomyosis
-
Dec 13, 2025, 04:22Placenta-Targeted Nanoparticles: A New Frontier in Recurrent Pregnancy Loss – Reproduction and Fertility